| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 780,794 | 813,379 | 738,530 | 921,534 | | Cost of Revenue | 633,166 | 675,597 | 621,399 | 754,801 | | | Gross Profit | 147,628 | 137,782 | 117,131 | 166,733 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 71,018 | 72,970 | 73,603 | 82,265 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 5,448 | 4,906 | 4,906 | 6,836 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 71,162 | 59,906 | 38,622 | 77,632 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 930 | 786 | 1,157 | 1,594 | | Earnings Before Interest And Taxes | 72,092 | 60,692 | 39,779 | 79,226 | | Interest Expense | 2,816 | 2,803 | 2,818 | 1,863 | | Income Before Tax | 69,276 | 57,889 | 36,961 | 77,363 | | Income Tax Expense | 5,320 | 24,245 | 15,471 | 30,250 | | Minority Interest | (873) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 63,083 | 33,644 | 21,490 | 47,113 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 63,083 | 33,644 | 21,490 | 47,113 | | Preferred Stock And Other Adjustments | 353 | (217) | (136) |
-
| | | Net Income Applicable To Common Shares | $63,436 | $33,427 | $21,354 | $47,113 |
|
0.34% Nasdaq 
Income Statement
